Abstract: Epilepsy is one of the five major neuropsychiatric diseases that the World Health Organization focuses on. There are more than 10 million people with epilepsy in China, which lead to tremendous burden of disease. Fortunately, over 70% of epilepsy patients can achieve the treatment goal of seizure control and reintegration into society under standardized treatment. Improving the qualityof diagnosis and treatment of epilepsy can effectively improve the accessibility of medical care in people with epilepsy in China. In 2017, with the support of the National Health Commission, the National Center for Healthcare Quality Management in Neurological Diseases set up the Epilepsy Medical Working Group to start the construction of the medical quality control system in epilepsy and convulsive status epilepticus. The construction of medical quality control system for epilepsy and convulsive status epilepticus strengthened the national epilepsy management system, found out the status of diagnosis and treatment in China, built a dynamic feedback mechanism for the medical quality system with multiple data sources complementing each other. Applying medical quality tools for epilepsy and convulsive status epilepticus, which have continued to promote the homogenization of epilepsy diagnosis and treatment in China.

Key words: Medical quality; Quality control indicator; Epilepsy; Paroxysmal disease; Convulsive status epilepticus

摘要： 癫痫是世界卫生组织重点防治的五大神经精神疾病之一，在我国有超1000万人受累，疾病负担沉重。经规范治疗，70%以上的癫痫患者可达到控制发作、重返社会的治疗目标。提高癫痫诊疗质量可有效改善我国癫痫医疗的可及性。2017年，在国家卫生健康委员会的支持下，国家神经系统疾病医疗质量控制中心成立了癫痫质控专病组，启动了癫痫及惊厥性癫痫持续状态医疗质量控制体系建设。癫痫及惊厥性癫痫持续状态医疗质量控制体系建设强化了我国的癫痫诊疗体系，调查了我国癫痫诊治现状，建设了数据来源互补医疗质量体系动态反馈机制。应用癫痫及惊厥性癫痫持续状态医疗质量工具可持续推动我国癫痫诊疗质量的同质化发展。

关键词: 医疗质量; 质量控制指标; 癫痫; 发作性疾病; 惊厥性癫痫持续状态